Erin Wright
Stock Analyst at Morgan Stanley
(1.49)
# 1677
Out of 5,370 analysts
281
Total ratings
63.03%
Success rate
2.74%
Average return
Main Sectors:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
CAH Cardinal Health | Maintains: Overweight | 166 181 | 162.27 | 11.54% | 11 | Jun 13, 2025 | |
MCK McKesson | Maintains: Overweight | 745 770 | 719.35 | 7.04% | 7 | Jun 11, 2025 | |
PAHC Phibro Animal Health | Maintains: Equal-Weight | 20 21 | 24.69 | -14.95% | 21 | May 8, 2025 | |
IDXX IDEXX Laboratories | Maintains: Overweight | 548 558 | 528.44 | 5.59% | 13 | May 5, 2025 | |
CI Cigna Group | Maintains: Overweight | 379 390 | 313.86 | 24.26% | 5 | May 5, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 4 4 | 3.6 | -11.11% | 12 | Apr 17, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 20 19 | 19.05 | -0.26% | 8 | Mar 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 14 13 | 14.01 | -7.21% | 11 | Feb 26, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 243 238 | 164.2 | 44.95% | 7 | Feb 14, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 301 285 | 235.4 | 21.07% | 3 | Feb 12, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 280 272 | 182.34 | 49.17% | 21 | Feb 6, 2025 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 27 32 | n/a | n/a | 7 | Dec 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 30 23 | 15.93 | 44.38% | 12 | Dec 17, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 643 551 | 376.51 | 46.34% | 2 | Oct 23, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 9 7 | 11.4 | -38.6% | 7 | Oct 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 69 65 | 70.73 | -8.1% | 4 | Nov 14, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 1000 920 | n/a | n/a | 6 | Nov 9, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 110 100 | 67.73 | 47.65% | 4 | Nov 2, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 587 587 | 307.61 | 90.83% | 3 | Jul 14, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 58 | n/a | n/a | 5 | Jan 6, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Overweight | 300 | 263.67 | 13.78% | 4 | Aug 22, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Assumes: Equal-Weight | 142 | 182.06 | -22% | 4 | Aug 22, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 2 1 | n/a | n/a | 5 | Aug 10, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 19 21 | n/a | n/a | 6 | May 23, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 39 42 | 13.43 | 212.73% | 5 | Jul 30, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 282 288 | 200.98 | 43.3% | 6 | Jun 18, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 15 14 | n/a | n/a | 2 | Jun 17, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 342 352 | 151.28 | 132.68% | 4 | May 28, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 42 44 | 2.15 | 1946.51% | 2 | May 11, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 159 169 | n/a | n/a | 6 | Apr 29, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 178 181 | 300.75 | -39.82% | 8 | Mar 17, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 14 17 | 77.64 | -78.1% | 6 | Feb 26, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 21 | n/a | n/a | 1 | Feb 22, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 104 121 | 41.69 | 190.24% | 7 | Jan 13, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 556 580 | 404.82 | 43.27% | 4 | Jan 12, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 35 | 10.76 | 225.28% | 1 | Jan 5, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 181 205 | 146.97 | 39.48% | 2 | Jul 23, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 32 30 | n/a | n/a | 1 | May 7, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 12 11 | 20.92 | -47.42% | 6 | May 5, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 175 157 | 159.4 | -1.51% | 1 | Apr 2, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 72 62 | n/a | n/a | 2 | Apr 2, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 34 30 | n/a | n/a | 4 | Feb 24, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 6 5 | n/a | n/a | 3 | Nov 18, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 3 | Apr 30, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 90 97 | n/a | n/a | 3 | Sep 18, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 42 38 | 22.27 | 70.63% | 1 | May 9, 2018 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underperform | 31 17 | 7.92 | 114.65% | 1 | Nov 20, 2017 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 300 308 | 466.6 | -33.99% | 1 | Oct 25, 2017 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 71 | n/a | n/a | 1 | Aug 7, 2017 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 1 | Aug 4, 2017 |